Pembrolizumab (pembrolizumab) is a humanized anti-PD-1 monoclonal antibody that blocks the interaction between PD-1 and its ligands PD-L1 and PD-L2. It has immune checkpoint inhibitory activity and antitumor activity. MW: 146.286 KD.(Pembrolizumab does not recognize murine PD-1 protein, humanized mice or mice expressing human PD-1 gene are required).
Purity:
>99.0%
CAS Number:
[1374853-91-4]
Target:
PD-1/PD-L1
* VAT and and shipping costs not included. Errors and price changes excepted
